Carcinogenicity of acrolein, crotonaldehyde, and arecoline
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F60461373%3A22310%2F21%3A43922699" target="_blank" >RIV/60461373:22310/21:43922699 - isvavai.cz</a>
Result on the web
<a href="https://www.sciencedirect.com/science/article/pii/S1470204520307270" target="_blank" >https://www.sciencedirect.com/science/article/pii/S1470204520307270</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/S1470-2045(20)30727-0" target="_blank" >10.1016/S1470-2045(20)30727-0</a>
Alternative languages
Result language
angličtina
Original language name
Carcinogenicity of acrolein, crotonaldehyde, and arecoline
Original language description
In October–November, 2020, a Working Group of 20 scientists from ten countries met remotely at the invitation of the International Agency for Research on Cancer (IARC) to finalise their evaluations of the carcinogenicity of acrolein, crotonaldehyde, and arecoline. Acrolein was classified as “probably carcinogenic to humans” (Group 2A) on the basis of “sufficient” evidence of carcinogenicity in experimental animals and “strong” mechanistic evidence. Crotonaldehyde and arecoline were classified as “possibly carcinogenic to humans” (Group 2B) on the basis of “strong” mechanistic evidence. For all three agents, the evidence regarding cancer in humans was “inadequate”; no data were available for arecoline, and the few available studies of cancer in humans for acrolein and crotonaldehyde were generally small or uninformative. These assessments will be published in volume 128 of the IARC Monographs.1
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30304 - Public and environmental health
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2021
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
The Lancet Oncology
ISSN
1470-2045
e-ISSN
—
Volume of the periodical
22
Issue of the periodical within the volume
1
Country of publishing house
NL - THE KINGDOM OF THE NETHERLANDS
Number of pages
2
Pages from-to
19-20
UT code for WoS article
000610553800030
EID of the result in the Scopus database
2-s2.0-85099326297